Literature DB >> 12431385

How do inhibitory phosphatases work?

K M Coggeshall1, Koji Nakamura, Hyewon Phee.   

Abstract

We present a hypothesis regarding the mode of induction of the inhibitory phosphatases SHP-1 and SHIP in hematopoietic cells. One mode is a general one in which the phosphatase regulates but does not abort signal transduction and biology. Regulator phosphatases are induced by directly or indirectly engaging the amino acid motifs present in the activating receptor, and act to control the biochemical and biological output. The other mode of induction is a specific one, which critically involves paired co-clustering of activating and inhibitory receptors. Phosphatases working in this way act only under conditions of paired co-clustering of activating and inhibitory receptors, and directly bind amino acid motifs present in the inhibitory receptor. However, this mode of induction is apparently more efficient, as cellular activation is completely aborted. This review presents several examples of each mode of inhibition and speculates on their mechanisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12431385     DOI: 10.1016/s0161-5890(02)00209-2

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  9 in total

1.  The inositol phosphatase SHIP-2 down-regulates FcgammaR-mediated phagocytosis in murine macrophages independently of SHIP-1.

Authors:  Jing Ai; Amita Maturu; Wesley Johnson; Yijie Wang; Clay B Marsh; Susheela Tridandapani
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

2.  Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP).

Authors:  Ya-Hui Chiu; Kofi A Mensah; Edward M Schwarz; Yawen Ju; Masahiko Takahata; Changyong Feng; Loralee A McMahon; David G Hicks; Ben Panepento; Peter C Keng; Christopher T Ritchlin
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

3.  TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1.

Authors:  Qisheng Peng; Shikha Malhotra; James A Torchia; William G Kerr; K Mark Coggeshall; Mary Beth Humphrey
Journal:  Sci Signal       Date:  2010-05-18       Impact factor: 8.192

Review 4.  The role and target potential of protein tyrosine phosphatases in cancer.

Authors:  Taolin Yi; Daniel Lindner
Journal:  Curr Oncol Rep       Date:  2008-03       Impact factor: 5.075

5.  Large-scale identification of disease genes involved in acute myeloid leukemia.

Authors:  Stefan J Erkeland; Marijke Valkhof; Claudia Heijmans-Antonissen; Antoinette van Hoven-Beijen; Ruud Delwel; Mirjam H A Hermans; Ivo P Touw
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

6.  Differential association of phosphatidylinositol 3-kinase, SHIP-1, and PTEN with forming phagosomes.

Authors:  Lynn A Kamen; Jonathan Levinsohn; Joel A Swanson
Journal:  Mol Biol Cell       Date:  2007-04-18       Impact factor: 4.138

7.  Calpain/SHP-1 interaction by honokiol dampening peritoneal dissemination of gastric cancer in nu/nu mice.

Authors:  Shing Hwa Liu; Keh Bin Wang; Keng Hsin Lan; Wen Jane Lee; Hung Chuan Pan; Sheng Mao Wu; Yen Chun Peng; Yi Ching Chen; Chin Chang Shen; Hsu Chen Cheng; Ko Kaung Liao; Meei Ling Sheu
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

8.  Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects.

Authors:  Taolin Yi; Paul Elson; Masato Mitsuhashi; Barbara Jacobs; Emese Hollovary; Thomas G Budd; Timothy Spiro; Pierre Triozzi; Ernest C Borden
Journal:  Oncotarget       Date:  2011-12

9.  Regulation of autoimmune arthritis by the SHP-1 tyrosine phosphatase.

Authors:  Adrienn Markovics; Daniel M Toth; Tibor T Glant; Katalin Mikecz
Journal:  Arthritis Res Ther       Date:  2020-06-26       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.